Evidence map›Paper›PMID 30631041›Full record

ArticleCell death & disease2019

Gene expression, proteome and calcium signaling alterations in immortalized hippocampal astrocytes from an Alzheimer's disease mouse model.

Francesca Rocchio, Laura Tapella, Marcello Manfredi, Mariangela Chisari, Francesca Ronco, Federico Alessandro Ruffinatti, Eleonora Conte, Pier Luigi Canonico, Maria Angela Sortino, Mariagrazia Grilli and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Intracellular CaFrontiers in physiology · 2023
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Francesca RocchioDepartment of Pharmaceutical Sciences, Università degli Studi del Piemonte Orientale, Novara, Italy.
Laura TapellaDepartment of Pharmaceutical Sciences, Università degli Studi del Piemonte Orientale, Novara, Italy.
Marcello ManfrediDepartment of Sciences and Technological Innovation, Università degli Studi del Piemonte Orientale, Alessandria, Italy.
Mariangela ChisariDepartment of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania, Via Santa Sofia, 97, 95123, Catania, Italy.
Francesca RoncoDepartment of Pharmaceutical Sciences, Università degli Studi del Piemonte Orientale, Novara, Italy.
Federico Alessandro RuffinattiDepartment of Pharmaceutical Sciences, Università degli Studi del Piemonte Orientale, Novara, Italy.
Eleonora ConteDepartment of Sciences and Technological Innovation, Università degli Studi del Piemonte Orientale, Alessandria, Italy.
Pier Luigi CanonicoDepartment of Pharmaceutical Sciences, Università degli Studi del Piemonte Orientale, Novara, Italy.
Maria Angela SortinoDepartment of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania, Via Santa Sofia, 97, 95123, Catania, Italy.
Mariagrazia GrilliDepartment of Pharmaceutical Sciences, Università degli Studi del Piemonte Orientale, Novara, Italy.ORCID http://orcid.org/0000-0001-9165-5827
Emilio MarengoDepartment of Sciences and Technological Innovation, Università degli Studi del Piemonte Orientale, Alessandria, Italy.
Armando A GenazzaniDepartment of Pharmaceutical Sciences, Università degli Studi del Piemonte Orientale, Novara, Italy. armando.genazzani@uniupo.it.
Dmitry LimDepartment of Pharmaceutical Sciences, Università degli Studi del Piemonte Orientale, Novara, Italy. dmitry.lim@uniupo.it.ORCID http://orcid.org/0000-0002-4316-2654
Università degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITUniversity of Catania · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evidence is rapidly growing regarding a role of astroglial cells in the pathogenesis of Alzheimer's disease (AD), and the hippocampus is one of the important brain regions affected in AD. While primary astroglial cultures, both from wild-type mice and from rodent models of AD, have been useful for studying astrocyte-specific alterations, the limited cell number and short primary culture lifetime have limited the use of primary hippocampal astrocytes. To overcome these limitations, we have now established immortalized astroglial cell lines from the hippocampus of 3xTg-AD and wild-type control mice (3Tg-iAstro and WT-iAstro, respectively). Both 3Tg-iAstro and WT-iAstro maintain an astroglial phenotype and markers (glutamine synthetase, aldehyde dehydrogenase 1 family member L1 and aquaporin-4) but display proliferative potential until at least passage 25. Furthermore, these cell lines maintain the potassium inward rectifying (Kir) current and present transcriptional and proteomic profiles compatible with primary astrocytes. Importantly, differences between the 3Tg-iAstro and WT-iAstro cell lines in terms of calcium signaling and in terms of transcriptional changes can be re-conducted to the changes previously reported in primary astroglial cells. To illustrate the versatility of this model we performed shotgun mass spectrometry proteomic analysis and found that proteins related to RNA binding and ribosome are differentially expressed in 3Tg-iAstro vs WT-iAstro. In summary, we present here immortalized hippocampal astrocytes from WT and 3xTg-AD mice that might be a useful model to speed up research on the role of astrocytes in AD.

Indexed as

Calcium SignalingGene ExpressionProteomeAlzheimer DiseaseAnimalsAstrocytesCells, CulturedDisease Models, AnimalExcitatory Amino Acid Transporter 2Glutamic AcidHippocampusMiceMice, Inbred C57BLMice, TransgenicProtein Interaction MapsSynaptic TransmissionExcitatory Amino Acid Transporter 2Glutamic AcidProteomeSlc1a2 protein, mouse

Identifiers

PMID30631041
PMCPMC6328590
OpenAlexW4234108832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.